Ph. Sato et al., DIFFERENCES IN THE INHIBITION OF TRANSLATION BY CISPLATIN, TRANSPLATIN, AND CERTAIN RELATED-COMPOUNDS, Biochemical pharmacology, 52(12), 1996, pp. 1895-1902
The non-therapeutic cisplatin congeners transplatin and chloroethylene
triamine platinum (dien) inhibited translation to a similar extent as
cisplatin did. The IC50 values were: cisplatin 23 mu M, transplatin 54
mu M, and dien 117 mu M. Unlike certain heavy metal inhibitors of tra
nslation, the effect of neither cisplatin nor the congeners was revers
ed by 3':5'-cyclic adenosine monophosphate (cAMP). This suggests that
the effect of these platinum compounds does not occur by the heavy met
al mechanism. Polyribosomes and ribosomal subunits formed in transplat
in-inhibited reactions differed from those in reactions inhibited by c
isplatin. Specifically, large polyribosomes and complete 80S ribosomal
subunits accumulated in the presence of transplatin. This indicates t
hat while cisplatin slowed initiation of peptide synthesis, the trans-
isomer slowed elongation. Substantive differences were not found betwe
en cisplatin and the monofunctional compound dien. This congener incre
ased the non-peptidyl disintegrations per minute in the acid precipita
tes of assays containing [(35)]methionine. The high background indicat
ed that an interaction between the label and a precipitable component
of the system was induced by dien. However, consumption of methionine
by this interaction did not appear to be the cause of the inhibition.
Although there may be differences in the mechanisms of the effects, th
e finding that the non-therapeutic congeners inhibit translation at si
milar concentrations as cisplatin suggests that this inhibition is not
responsible for the anticancer effect. On the other hand, the possibi
lity that decreased translation could play an important role in the to
xicity of these compounds in certain quiescent cells cannot be ruled o
ut. Copyright (C) 1996 Elsevier Science Inc.